Two-once-daily fixed-dose NRTI combinations for HIV. The Medical letter on drugs and therapeutics. [Med Lett Drugs Ther] Journal article

Title	Two-once-daily fixed-dose NRTI combinations for HIV.
Source	Med Lett Drugs Ther 2005 Feb 28; 47(1203):19-20.
MeSH	Anti-HIV Agents Deoxycytidine Dose-Response Relationship, Drug Drug Combinations Drug Hypersensitivity HIV Infections Humans Lamivudine Organophosphorus Compounds
Abstract	Abacavir/lamivudine (Epzicom) and emtricitabine/tenofovir (Truvada), two new once-daily fixed-dose NRTI combinations, have been approved for use in antiretroviral regimens to treat HIV infection. Epzicom appears to be as effective as its components taken separately and, in one study, Truvada was at least as effective as zidovudine/lamivudine (Combivir). Use of once-daily fixed-dose combinations means less flexibility in dosing, and some patients with hepatic or renal impairment will not be able to take them.
Language	eng
Pub Type(s)	Journal Article
PubMed ID	15767973

Advertise on this site.